Normalized spleen/liver ratios on in-labelled platelet scintigraphy to predict the outcome of partial splenic embolization in patients with idiopathic thrombocytopenic purpura

Nuclear Medicine Communications

Volumn 21, Issue 5, 2000, Pages 441-447

  Uchida, Y ^a   Minoshima, S ^a   Miyazaki, M ^a   Kuyama, J ^a   Kitahara, H ^a   Ito, H ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER; MALE; METABOLISM; PROSPECTIVE STUDY; SCINTISCANNING; SPLEEN; THROMBOCYTE; THROMBOCYTE COUNT;

ADULT; BLOOD PLATELETS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LIVER; MALE; PLATELET COUNT; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLEEN;

EID: 0034181163     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200005000-00006     Document Type: Article

References (26)

1. Pizzuto J, Ambriz R. Therapeutic experience of 934 adults with idiopathic thrombocytopenic purpura: Multicentric trial of the cooperative Latin American group on hemostasis thrombosis. Blood 1984; 64: 1179-1183.
2. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74: 2309-2317.
3. Fabris F, Zanatta N, Casonato A, Randi ML, Luzzatto G, Girolami A. Response to splenectomy in idiopathic thrombocytopenic purpura: Prognostic value of the clinical and laboratory evaluation. Acta Haemat 1989; 81: 28-33.
4. Fenaux P, Caulier MT, Hirschauer MC, Beuscart R, Goudemand J, Bauters F. Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): A report on 181 cases. Eur J Haematol 1989; 42: 259-264.
5. Julia A, Araguas C, Rossello J et al. Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 1990; 76: 250-255.
6. Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. Am J Roentgenol 1979; 132: 777-782.
7. Ji SQ, Huang ZY, Gu GL. Splenic embolization therapy of idiopathic thrombocytopenic purpura. Chung Hua Nei Ko Tsa Chih 1991; 30: 682-684.
8. Miyazaki M, Itoh H, Kaiho T et al. Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR 1994; 163: 123-126.
9. Ries CA. Platelets kinetics in auto-immune thrombocytopenia: Relation between splenic platelet sequestration and response to splenectomy. Ann Intern Med 1977; 86: 194-195.
10. Siegel RS, Rae JL, Barth S et al. Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol 1989; 30: 206-212.
11. Najean Y, Dufour V, Rain JD, Toubert ME. The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy. Br J Haematol 1991; 79: 271-276.
12. Lamy T, Moisan A, Dauriac C, Ghandour C, Morice P, Le Prise PY. Splenectomy in idiopathic thrombocytopenic purpura: Its correlation with the sequestration of autologous indium-111-labeled platelets. J Nucl Med 1993; 33: 182-186.
13. Nomura T. Idiopathic Hematopoietic Disorders Research Committee of Japanese Ministry of Health. Tokyo: Ministry of Health, 1992: 1-22.
14. Dewanjee MK, Rao SA, Didisheim P. Indium-111 tropolone, a new high-affinity platelet label: Preparation and evaluation of labeling parameters. J Nucl Med 1981; 22: 981-987.
15. Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 1985; 65: 584-588.
16. 111In-labelled platelets in organs. Eur J Nucl Med 1982; 7: 80-84.
17. Peters AM, Saverymuttu SH, Bell RN, Lavender JP. The kinetics of short-lived indium-111 radiolabelled platelets. Scand J Haematol 1985; 34: 137-145.
18. Stasi R, Stipa E, Masi M et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995; 98: 436-442.
19. Difino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura: Clinical findings and response to therapy. Am J Med 1980; 69: 430-442.
20. Mintz SJ, Peterson SR, Cheson B, Cordell LJ, Richards RC. Splenectomy for immune thrombocytopenic purpura. Arch Surg 1981; 116: 645-650.
21. Kaiho T, Miyazaki M, Iinuma K et al. Long-term prognosis of idiopathic thrombocytopenic purpura treated by partial splenic embolization. Nippon Geka Gakkai Zasshi 1993; 94: 383-393.
22. Baldini M. Idiopathic thrombocytopenic purpura. N Engl J Med 1966; 274: 1245-1251, 1301-1306, 1360-1367.
23. Gernsheimer T, Stratton J, Ballem PJ, Slichter SJ. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 1989; 320: 974-980.
24. Stratton JR, Ballem PJ, Gernsheimer T, Cerqueira M, Slichter SJ. Platelet destruction in autoimmune thrombocytopenic purpura: Kinetics and clearance of indium-111-labeled autologous platelets. J Nucl Med 1989; 30: 629-637.
25. Peters AM, Klonizakis I, Lavender JP, Lewis SM. Elution of 111Indium from reticuloendothelial cells. J Clin Pathol 1992; 35: 507-509.
26. Peters AM, Saverymuttu SH, Wonke B, Lewis SM, Lavender JP. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction. Br J Haematol 1994; 57: 637-649.